880
Participants
Start Date
February 2, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2028
Troponin surveillance
Troponin will be monitored prior to each immune checkpoint inhibitor infusion for the first 12 weeks of therapy.
Standard of care
Standard of care if symptoms arise then evaluation with cardiac biomarkers and/or further cardiac testing.
RECRUITING
MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER